October 28, 2024
Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates
Media
October 24, 2024
BONESUPPORT HOLDING AB (publ) – publishes Q3 2024 Interim report
October 22, 2024
Ariceum Therapeutics Presents Outstanding Data on its First-in-Class Radiopharmaceutical Drug 225Ac-Satoreotide at the European Association of Nuclear Medicine 2024
October 22, 2024
Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell Therapy Annual Congress 2024
October 18, 2024
Correction: BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q3 2024
October 17, 2024
BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q3 2024
October 16, 2024
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
October 09, 2024
Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development
October 08, 2024
Adcendo Announces US FDA Clearance of IND Application for Phase I/II First-in-Human ADCElerate-01 Trial of ADCE-D01 (uPARAP Receptor Targeting ADC) Trial in Patients with Metastatic and/or Unresectable Soft Tissue Sarcoma (STS)
October 07, 2024
Vicore Pharma has successfully carried out a directed share issue of approximately SEK 100 million